| Product Code: ETC9137388 | Publication Date: Sep 2024 | Updated Date: Jan 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sao Tome and Principe Antimicrobial Resistance Market Overview |
3.1 Sao Tome and Principe Country Macro Economic Indicators |
3.2 Sao Tome and Principe Antimicrobial Resistance Market Revenues & Volume, 2021 & 2031F |
3.3 Sao Tome and Principe Antimicrobial Resistance Market - Industry Life Cycle |
3.4 Sao Tome and Principe Antimicrobial Resistance Market - Porter's Five Forces |
3.5 Sao Tome and Principe Antimicrobial Resistance Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Sao Tome and Principe Antimicrobial Resistance Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Sao Tome and Principe Antimicrobial Resistance Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.8 Sao Tome and Principe Antimicrobial Resistance Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
4 Sao Tome and Principe Antimicrobial Resistance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Sao Tome and Principe Antimicrobial Resistance Market Trends |
6 Sao Tome and Principe Antimicrobial Resistance Market, By Types |
6.1 Sao Tome and Principe Antimicrobial Resistance Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Sao Tome and Principe Antimicrobial Resistance Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Sao Tome and Principe Antimicrobial Resistance Market Revenues & Volume, By Complicated Urinary Tract Infections (cUTI), 2021- 2031F |
6.1.4 Sao Tome and Principe Antimicrobial Resistance Market Revenues & Volume, By Blood stream infections, 2021- 2031F |
6.1.5 Sao Tome and Principe Antimicrobial Resistance Market Revenues & Volume, By Acute bacterial skin and skin structure infections (ABSSSI), 2021- 2031F |
6.1.6 Sao Tome and Principe Antimicrobial Resistance Market Revenues & Volume, By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP), 2021- 2031F |
6.1.7 Sao Tome and Principe Antimicrobial Resistance Market Revenues & Volume, By Community acquired pneumonia (CAP), 2021- 2031F |
6.1.8 Sao Tome and Principe Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Sao Tome and Principe Antimicrobial Resistance Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Sao Tome and Principe Antimicrobial Resistance Market Revenues & Volume, By Combination therapies, 2021- 2031F |
6.2.3 Sao Tome and Principe Antimicrobial Resistance Market Revenues & Volume, By Tetracyclines, 2021- 2031F |
6.2.4 Sao Tome and Principe Antimicrobial Resistance Market Revenues & Volume, By Cephalosporins, 2021- 2031F |
6.2.5 Sao Tome and Principe Antimicrobial Resistance Market Revenues & Volume, By Glycopeptides and Lipoglycopeptides, 2021- 2031F |
6.2.6 Sao Tome and Principe Antimicrobial Resistance Market Revenues & Volume, By Oxazolidinones, 2021- 2031F |
6.2.7 Sao Tome and Principe Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Sao Tome and Principe Antimicrobial Resistance Market, By Mechanism of Action |
6.3.1 Overview and Analysis |
6.3.2 Sao Tome and Principe Antimicrobial Resistance Market Revenues & Volume, By Protein Synthesis Inhibitors, 2021- 2031F |
6.3.3 Sao Tome and Principe Antimicrobial Resistance Market Revenues & Volume, By Cell Wall Synthesis Inhibitors, 2021- 2031F |
6.3.4 Sao Tome and Principe Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Sao Tome and Principe Antimicrobial Resistance Market, By Pathogen |
6.4.1 Overview and Analysis |
6.4.2 Sao Tome and Principe Antimicrobial Resistance Market Revenues & Volume, By Klebsiella pneumoniae, 2021- 2031F |
6.4.3 Sao Tome and Principe Antimicrobial Resistance Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.4.4 Sao Tome and Principe Antimicrobial Resistance Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.4.5 Sao Tome and Principe Antimicrobial Resistance Market Revenues & Volume, By Enterococcus Spp, 2021- 2031F |
6.4.6 Sao Tome and Principe Antimicrobial Resistance Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.4.7 Sao Tome and Principe Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
7 Sao Tome and Principe Antimicrobial Resistance Market Import-Export Trade Statistics |
7.1 Sao Tome and Principe Antimicrobial Resistance Market Export to Major Countries |
7.2 Sao Tome and Principe Antimicrobial Resistance Market Imports from Major Countries |
8 Sao Tome and Principe Antimicrobial Resistance Market Key Performance Indicators |
9 Sao Tome and Principe Antimicrobial Resistance Market - Opportunity Assessment |
9.1 Sao Tome and Principe Antimicrobial Resistance Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Sao Tome and Principe Antimicrobial Resistance Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Sao Tome and Principe Antimicrobial Resistance Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.4 Sao Tome and Principe Antimicrobial Resistance Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
10 Sao Tome and Principe Antimicrobial Resistance Market - Competitive Landscape |
10.1 Sao Tome and Principe Antimicrobial Resistance Market Revenue Share, By Companies, 2024 |
10.2 Sao Tome and Principe Antimicrobial Resistance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here